HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience

HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience

Hepatitis B virus reactivation (HBVr) can develop in HBV surface antigen (HBsAg) positive or HBsAg-negative and anti-hepatitis B core antigen antibodies (anti-HBc) positive (past HBV infection) patients receiving immuno-chemotherapy for hematological malignancies. A higher rate of HBVr is associated...

Full description

Bibliographic Details
Main Authors: Michele Clerico, Irene Dogliotti, Paola Ghione, Vittorio Ruggero Zilioli, Francesco Merli, Barbara Botto, Wael Al Essa, Marcella Battaglini, Daniele Grimaldi, Loretta Cervi, Simone Ragaini, Simone Ferrero, Veronica Peri, Gabriele De Luca, Alfredo Marzano, Federica Cavallo
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Journal of Personalized Medicine
Subjects:
hepatitis B virus (HBV)
non-Hodgkin lymphoma (NHL)
HBV reactivation (HBVr)
rituximab
lamivudine (LAM)
Online Access:https://www.mdpi.com/2075-4426/12/2/285

Internet

https://www.mdpi.com/2075-4426/12/2/285

Similar Items